Loading…

Exploiting mesoporous silica nanoparticles as versatile drug carriers for several routes of administration

The exploitation of mesoporous silica nanoparticles (MSNs) as drug delivery systems has grown exponentially due to their remarkable tunable properties, such as high surface area, chemical and physical stability, high loading and release capacities, distinct possibilities of particle and pore structu...

Full description

Saved in:
Bibliographic Details
Published in:Microporous and mesoporous materials 2021-01, Vol.312, p.110774, Article 110774
Main Authors: Sábio, Rafael Miguel, Meneguin, Andréia Bagliotti, Martins dos Santos, Aline, Monteiro, Andreia Sofia, Chorilli, Marlus
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c315t-3a67ae91cb5ea807b1c8bba16c0522a43b15fd7a042f65fd1660a333e15ec5d3
cites cdi_FETCH-LOGICAL-c315t-3a67ae91cb5ea807b1c8bba16c0522a43b15fd7a042f65fd1660a333e15ec5d3
container_end_page
container_issue
container_start_page 110774
container_title Microporous and mesoporous materials
container_volume 312
creator Sábio, Rafael Miguel
Meneguin, Andréia Bagliotti
Martins dos Santos, Aline
Monteiro, Andreia Sofia
Chorilli, Marlus
description The exploitation of mesoporous silica nanoparticles (MSNs) as drug delivery systems has grown exponentially due to their remarkable tunable properties, such as high surface area, chemical and physical stability, high loading and release capacities, distinct possibilities of particle and pore structures, as well as good biocompatibility, biodegradability, and easy clearance. However, the main exposure routes that exploit MSNs qualities, namely intravenous, subcutaneous, intramuscular, intratumoral, ophthalmic, pulmonary, nasal, dermal, and oral administrations, have been underreported to date. In addition, a better understanding of these administration routes can contribute to the development of smart MSNs-based nanoplatforms with interesting properties, such as high stability in physiological media, specificity and efficacy in theranostic applications, and further clinical translations. This review highlights the advantages and challenges of the administration routes aforementioned regarding the MSNs as drug delivery systems. It also shows how their properties can influence the interaction with biological media, and consequently, their biocompatibility, biodistribution, and clearance mostly in pre-clinical assays, in order to contribute to further MSNs-based nanoplatform clinical translations. [Display omitted] •Better understanding of the administration routes can contribute to the development of smart MSNs-based nanoplatforms.•The main exposure routes that exploit MSNs qualities have been underreported to date.•Size, morphology, porosity, surface charge, and modification influence biological behavior of MSNs.•Multifunctional MSNs are amazing drug delivery platforms for therapeutic purposes.
doi_str_mv 10.1016/j.micromeso.2020.110774
format article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1016_j_micromeso_2020_110774</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1387181120307745</els_id><sourcerecordid>S1387181120307745</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-3a67ae91cb5ea807b1c8bba16c0522a43b15fd7a042f65fd1660a333e15ec5d3</originalsourceid><addsrcrecordid>eNqFkN1qwzAMhc3YYF23Z5hfIJ0VN3F6WUr3A4Xd9N4ojlIckjjYbtnefg4du92VDpLOQfoYewaxAgHlS7carPFuoOBWuchTF4RS6xu2gErJTIqNvE1aViqDCuCePYTQCQEKcliwbv819c5GO574HDE5786BB9tbg3zE0U3oozU9BY6BX8gHjLYn3vjziRv03qYWb53ngdIUe54CYtp2LcdmsKMN0SeLGx_ZXYt9oKffumTH1_1x954dPt8-dttDZiQUMZNYKqQNmLogrISqwVR1jVAaUeQ5rmUNRdsoFOu8LZOCshQopSQoyBSNXDJ1jU1QQvDU6snbAf23BqFnYrrTf8T0TExfiSXn9uqkdN0l_aWDsTQaaqwnE3Xj7L8ZPxnyfOM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Exploiting mesoporous silica nanoparticles as versatile drug carriers for several routes of administration</title><source>ScienceDirect Freedom Collection</source><creator>Sábio, Rafael Miguel ; Meneguin, Andréia Bagliotti ; Martins dos Santos, Aline ; Monteiro, Andreia Sofia ; Chorilli, Marlus</creator><creatorcontrib>Sábio, Rafael Miguel ; Meneguin, Andréia Bagliotti ; Martins dos Santos, Aline ; Monteiro, Andreia Sofia ; Chorilli, Marlus</creatorcontrib><description>The exploitation of mesoporous silica nanoparticles (MSNs) as drug delivery systems has grown exponentially due to their remarkable tunable properties, such as high surface area, chemical and physical stability, high loading and release capacities, distinct possibilities of particle and pore structures, as well as good biocompatibility, biodegradability, and easy clearance. However, the main exposure routes that exploit MSNs qualities, namely intravenous, subcutaneous, intramuscular, intratumoral, ophthalmic, pulmonary, nasal, dermal, and oral administrations, have been underreported to date. In addition, a better understanding of these administration routes can contribute to the development of smart MSNs-based nanoplatforms with interesting properties, such as high stability in physiological media, specificity and efficacy in theranostic applications, and further clinical translations. This review highlights the advantages and challenges of the administration routes aforementioned regarding the MSNs as drug delivery systems. It also shows how their properties can influence the interaction with biological media, and consequently, their biocompatibility, biodistribution, and clearance mostly in pre-clinical assays, in order to contribute to further MSNs-based nanoplatform clinical translations. [Display omitted] •Better understanding of the administration routes can contribute to the development of smart MSNs-based nanoplatforms.•The main exposure routes that exploit MSNs qualities have been underreported to date.•Size, morphology, porosity, surface charge, and modification influence biological behavior of MSNs.•Multifunctional MSNs are amazing drug delivery platforms for therapeutic purposes.</description><identifier>ISSN: 1387-1811</identifier><identifier>EISSN: 1873-3093</identifier><identifier>DOI: 10.1016/j.micromeso.2020.110774</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Administration routes ; Biological behavior ; Drug delivery systems ; Mesoporous silica nanoparticles (MSNs)</subject><ispartof>Microporous and mesoporous materials, 2021-01, Vol.312, p.110774, Article 110774</ispartof><rights>2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-3a67ae91cb5ea807b1c8bba16c0522a43b15fd7a042f65fd1660a333e15ec5d3</citedby><cites>FETCH-LOGICAL-c315t-3a67ae91cb5ea807b1c8bba16c0522a43b15fd7a042f65fd1660a333e15ec5d3</cites><orcidid>0000-0002-6698-0545</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Sábio, Rafael Miguel</creatorcontrib><creatorcontrib>Meneguin, Andréia Bagliotti</creatorcontrib><creatorcontrib>Martins dos Santos, Aline</creatorcontrib><creatorcontrib>Monteiro, Andreia Sofia</creatorcontrib><creatorcontrib>Chorilli, Marlus</creatorcontrib><title>Exploiting mesoporous silica nanoparticles as versatile drug carriers for several routes of administration</title><title>Microporous and mesoporous materials</title><description>The exploitation of mesoporous silica nanoparticles (MSNs) as drug delivery systems has grown exponentially due to their remarkable tunable properties, such as high surface area, chemical and physical stability, high loading and release capacities, distinct possibilities of particle and pore structures, as well as good biocompatibility, biodegradability, and easy clearance. However, the main exposure routes that exploit MSNs qualities, namely intravenous, subcutaneous, intramuscular, intratumoral, ophthalmic, pulmonary, nasal, dermal, and oral administrations, have been underreported to date. In addition, a better understanding of these administration routes can contribute to the development of smart MSNs-based nanoplatforms with interesting properties, such as high stability in physiological media, specificity and efficacy in theranostic applications, and further clinical translations. This review highlights the advantages and challenges of the administration routes aforementioned regarding the MSNs as drug delivery systems. It also shows how their properties can influence the interaction with biological media, and consequently, their biocompatibility, biodistribution, and clearance mostly in pre-clinical assays, in order to contribute to further MSNs-based nanoplatform clinical translations. [Display omitted] •Better understanding of the administration routes can contribute to the development of smart MSNs-based nanoplatforms.•The main exposure routes that exploit MSNs qualities have been underreported to date.•Size, morphology, porosity, surface charge, and modification influence biological behavior of MSNs.•Multifunctional MSNs are amazing drug delivery platforms for therapeutic purposes.</description><subject>Administration routes</subject><subject>Biological behavior</subject><subject>Drug delivery systems</subject><subject>Mesoporous silica nanoparticles (MSNs)</subject><issn>1387-1811</issn><issn>1873-3093</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFkN1qwzAMhc3YYF23Z5hfIJ0VN3F6WUr3A4Xd9N4ojlIckjjYbtnefg4du92VDpLOQfoYewaxAgHlS7carPFuoOBWuchTF4RS6xu2gErJTIqNvE1aViqDCuCePYTQCQEKcliwbv819c5GO574HDE5786BB9tbg3zE0U3oozU9BY6BX8gHjLYn3vjziRv03qYWb53ngdIUe54CYtp2LcdmsKMN0SeLGx_ZXYt9oKffumTH1_1x954dPt8-dttDZiQUMZNYKqQNmLogrISqwVR1jVAaUeQ5rmUNRdsoFOu8LZOCshQopSQoyBSNXDJ1jU1QQvDU6snbAf23BqFnYrrTf8T0TExfiSXn9uqkdN0l_aWDsTQaaqwnE3Xj7L8ZPxnyfOM</recordid><startdate>202101</startdate><enddate>202101</enddate><creator>Sábio, Rafael Miguel</creator><creator>Meneguin, Andréia Bagliotti</creator><creator>Martins dos Santos, Aline</creator><creator>Monteiro, Andreia Sofia</creator><creator>Chorilli, Marlus</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-6698-0545</orcidid></search><sort><creationdate>202101</creationdate><title>Exploiting mesoporous silica nanoparticles as versatile drug carriers for several routes of administration</title><author>Sábio, Rafael Miguel ; Meneguin, Andréia Bagliotti ; Martins dos Santos, Aline ; Monteiro, Andreia Sofia ; Chorilli, Marlus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-3a67ae91cb5ea807b1c8bba16c0522a43b15fd7a042f65fd1660a333e15ec5d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Administration routes</topic><topic>Biological behavior</topic><topic>Drug delivery systems</topic><topic>Mesoporous silica nanoparticles (MSNs)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sábio, Rafael Miguel</creatorcontrib><creatorcontrib>Meneguin, Andréia Bagliotti</creatorcontrib><creatorcontrib>Martins dos Santos, Aline</creatorcontrib><creatorcontrib>Monteiro, Andreia Sofia</creatorcontrib><creatorcontrib>Chorilli, Marlus</creatorcontrib><collection>CrossRef</collection><jtitle>Microporous and mesoporous materials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sábio, Rafael Miguel</au><au>Meneguin, Andréia Bagliotti</au><au>Martins dos Santos, Aline</au><au>Monteiro, Andreia Sofia</au><au>Chorilli, Marlus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exploiting mesoporous silica nanoparticles as versatile drug carriers for several routes of administration</atitle><jtitle>Microporous and mesoporous materials</jtitle><date>2021-01</date><risdate>2021</risdate><volume>312</volume><spage>110774</spage><pages>110774-</pages><artnum>110774</artnum><issn>1387-1811</issn><eissn>1873-3093</eissn><abstract>The exploitation of mesoporous silica nanoparticles (MSNs) as drug delivery systems has grown exponentially due to their remarkable tunable properties, such as high surface area, chemical and physical stability, high loading and release capacities, distinct possibilities of particle and pore structures, as well as good biocompatibility, biodegradability, and easy clearance. However, the main exposure routes that exploit MSNs qualities, namely intravenous, subcutaneous, intramuscular, intratumoral, ophthalmic, pulmonary, nasal, dermal, and oral administrations, have been underreported to date. In addition, a better understanding of these administration routes can contribute to the development of smart MSNs-based nanoplatforms with interesting properties, such as high stability in physiological media, specificity and efficacy in theranostic applications, and further clinical translations. This review highlights the advantages and challenges of the administration routes aforementioned regarding the MSNs as drug delivery systems. It also shows how their properties can influence the interaction with biological media, and consequently, their biocompatibility, biodistribution, and clearance mostly in pre-clinical assays, in order to contribute to further MSNs-based nanoplatform clinical translations. [Display omitted] •Better understanding of the administration routes can contribute to the development of smart MSNs-based nanoplatforms.•The main exposure routes that exploit MSNs qualities have been underreported to date.•Size, morphology, porosity, surface charge, and modification influence biological behavior of MSNs.•Multifunctional MSNs are amazing drug delivery platforms for therapeutic purposes.</abstract><pub>Elsevier Inc</pub><doi>10.1016/j.micromeso.2020.110774</doi><orcidid>https://orcid.org/0000-0002-6698-0545</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1387-1811
ispartof Microporous and mesoporous materials, 2021-01, Vol.312, p.110774, Article 110774
issn 1387-1811
1873-3093
language eng
recordid cdi_crossref_primary_10_1016_j_micromeso_2020_110774
source ScienceDirect Freedom Collection
subjects Administration routes
Biological behavior
Drug delivery systems
Mesoporous silica nanoparticles (MSNs)
title Exploiting mesoporous silica nanoparticles as versatile drug carriers for several routes of administration
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T19%3A52%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exploiting%20mesoporous%20silica%20nanoparticles%20as%20versatile%20drug%20carriers%20for%20several%20routes%20of%20administration&rft.jtitle=Microporous%20and%20mesoporous%20materials&rft.au=S%C3%A1bio,%20Rafael%20Miguel&rft.date=2021-01&rft.volume=312&rft.spage=110774&rft.pages=110774-&rft.artnum=110774&rft.issn=1387-1811&rft.eissn=1873-3093&rft_id=info:doi/10.1016/j.micromeso.2020.110774&rft_dat=%3Celsevier_cross%3ES1387181120307745%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c315t-3a67ae91cb5ea807b1c8bba16c0522a43b15fd7a042f65fd1660a333e15ec5d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true